700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
|Jan M Keppel Hesselink|
|Jan M. Keppel Hesselink
Department of Medicine
University of Witten Herdecke
Dr. Jan M. Keppel Hesselink, MD, PhD is professor of molecular pharmacology at the university of Witten/Herdecke (Germany). He was elected as Fellow of the Pharmaceutical Faculty in Medicine (FFPM) in the UK. He worked several years at Bayer AG in Germany as VP CNS and business head CNS. He was advisor R&D and business strategies to the Dutch Royal Acadamy of Science (KNAW). Currently he is a consultant for life science companies and investors, founder of the Chonic Pain Coalition and of the Institute for Neuropathic Pain. His current focus is topical analgesic cream development and endocannabinoids as analgesics.
Dr. Jan M. Keppel Hesselink current focus is topical analgesic cream development and endocannabinoids as analgesics.
Global Speakers in the subject
Global Experts in the subject